Insights

John Brandsema, MD, and Julie Parsons, MD, review the diagnosis and optimal management of spinal muscular atrophy.

An expert neurologist provides insight into epilepsy treatments and various factors that impact patient compliance.

Key opinion leaders in the management of relapsing/remitting multiple sclerosis, Enrique Alvarez, MD, PhD and Lawrence Steinman, MD, review key factors to consider when using high-efficacy therapies and provide an overview of emerging data for potential new treatment options.

Key opinion leaders in neurology Tanuja Chitnis, MD and Lauren B. Krupp, MD discuss the diagnosis and treatment of pediatric multiple sclerosis (MS) and provide insight into the impact that results from the PARADIGM trial of fingolimod in pediatric patients may have on the treatment landscape.

Amit Verma, MD, reviews challenging epilepsy cases and their treatment.

David Dodick, MD, and Robert Cowan, MD, FAAN, review changes to the treatment landscape for acute migraine.